[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-IMMX":3,"homepage-market-summary":31,"stock-news-IMMX":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"IMMX","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Immix Biopharma, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.","21","Los Angeles, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},9.68,10.35,10.37,9.48,10.23,-0.55,-5.38,2545549.807456,19281,9.8043,15.1,1.995,1246046.989317616,58.6,1203,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},20,[176,182,188,194,200,205,211,217,223,229,235,240,246,251,256,261,266,272,277,283],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Immix plans to use about $117 million for treatment development and company operations - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxQTEw3bDNtZFlsQ1ZpMXpqZzVoNjNWdDlBZG5nNkZTU0U5UTIweFBjeWJ4dmd1WVZVYWtUd1Z2WXZtSmtWYmxNd254SkdtUjZka2RCT1JGeU1OSDFFWTdIZVN1Tk9KZnBYYXBsazBMY3JZaHdFLVRTR2ZHamdmZVVxVVd6VWxoR1MzUUs0VDhyaXpxbVBoVWZMYzRNcS1FNEtRbmtYYTlBUEg5S0ZYaC0zWFM0c05JM1E?oc=5","Wed, 30 Sep 2026 21:15:00 GMT","Immix plans to use about $117 million for treatment development and company operations Stock Titan","Stock Titan",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"BofA Raises Odds Of Success For Immix Biopharma’s NXC-201 Therapy — Sees Over 190% Upside In IMMX Stock - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxQaW5rbHlTNnJRTmFYUnRXR1ZBazA5QV9BVnc5VUZmZEw0Nm8zRjFwQlZZcGIzNEpLbDREdGxHaVMtYWFyLU1UVFFLNlctdGdFQjBXaUFpZG0zN24wRzRRakRFdnRxUTNoLVRGYUQyb0ZhWHJncWVpVUVUNmRRbkg1ZFBYd1dBWksxTkJ2M2d4MWtPUEQ5TlZTSlBsNksyQXhTampod2o3aG9ONFBBLXpONXpkRHZCOXRPdmh1Y0ZMQQ?oc=5","Tue, 29 Sep 2026 17:48:00 GMT","BofA Raises Odds Of Success For Immix Biopharma’s NXC-201 Therapy — Sees Over 190% Upside In IMMX Stock Stocktwits","Stocktwits",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Immix Biopharma Closes $125 Million Stock Offering - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxPR3dJN0poY1lCcHoxYlA4dHVxeXB2UWJTVzZ6ZnJtc2ZoRUVPbENZWUh4V3pzdW01cXlJLXlwckRybkhRYWZrWU1HblRDclFhbENneS1LcFRSblJzdWhkRHhWbDBfdGhab2J6Y1M0Zm90bE5jMW5qUmtrX1Z6ZERsejFDZ3hGR0tpVUFuN1drS2VEV25JYlVQOFB0Zw?oc=5","Wed, 30 Sep 2026 21:36:59 GMT","Immix Biopharma Closes $125 Million Stock Offering Yahoo Finance","Yahoo Finance",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Immix Biopharma Closes $117.1 Million Underwritten Registered Offering - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxOQU5MbzdSU1FqSHBGRHQ0Nk5WT3ZFNnRfVFJVSnhuWWtBT294QnBVNHFod2tvcjFMVnBJOWZDdEVpWW1BOV9MckR6Rmo1dy10NVdvRGo5OWplS0tkeFFFdFM1WEFjazE5ZUNDRm1RQVU1REJBbHdRU0pxcF9tMzdqckxJX0xnNmhQQURxVXlIQnNJejRXT3p4NUl3ejkzbEVxeTlBWkZpcGg?oc=5","Wed, 30 Sep 2026 21:20:00 GMT","Immix Biopharma Closes $117.1 Million Underwritten Registered Offering Quiver Quantitative","Quiver Quantitative",{"title":201,"link":202,"pubDate":179,"description":203,"source":204},"Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock - GlobeNewswire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi7wFBVV95cUxNSmJUd01RdmtDY3ZKVFE5OTRxYTJXMFFzdEJzMHdvaE9RQ295ajhOMjlfSXlSLXVtNWVqcWExdjFIMEZaV0lJcE5hVzBfQ2VydTZ0X3dVZG5MUXJ3RmR6WjZ6QmFTWExjR0U2d1ktclVKWmpWemJrc3FfU0U1NnhRcTdiM3NNVzZ3YTVmUTZVOWdXS3JRUTBtelhMMlFrM083RUJTeXJkcnhZTlZiZy1ZVERtRmtVYWhMenRFaERseTR0YjB3R3llOFBXcnk1RmE1ODkwLWNuQXJTYnkyMTlVcVNQaURYN3RKVHRYbmdCdw?oc=5","Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock GlobeNewswire","GlobeNewswire",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"Immix posts new trial data for AL amyloidosis drug (IMMX) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijAFBVV95cUxNYzVjXzFRMU1qRm5zNThyOTNoLTNoTjJVNnExQ1NqUWMyeDltOEhwMjAyUldHWU9OdHJTNDZybzdrYlBySFdQOEs5QURsQ1dCdDBrbzJpN1ItN1ZiLUZrVk1rVjBHbnlxRzAxdW1yMmw4cE1TWWhfbzRnUXFJZkFpSkk0Y0dIeHlrazYtMA?oc=5","Tue, 29 Sep 2026 13:13:39 GMT","Immix posts new trial data for AL amyloidosis drug (IMMX) Seeking Alpha","Seeking Alpha",{"title":212,"link":213,"pubDate":214,"description":215,"source":216},"Immix Biopharma prices $125M stock offering - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxQSFhpSGRMN0JlOXN0ZmQxMHBHZ2dqYnZZUjJiTmd1Q2RnQlZlSjQ1Z0VnTVBsLVRwWnRYZnZkdU44ZUpPOFhPWDM3bnl4alVpamEtWUpsNnlXRkd4X3gtUHJHRkRQamRxSFZLWkllRUhLZVR4Y05vRnZfZmV5Z0MyLVhxb1J1bm16RmRIM0R4VXZxUXFkSnoxMnBKaEVXWE5Nck9uUTZOX2M?oc=5","Tue, 29 Sep 2026 11:33:56 GMT","Immix Biopharma prices $125M stock offering TradingView","TradingView",{"title":218,"link":219,"pubDate":220,"description":221,"source":222},"We Think Immix Biopharma (NASDAQ:IMMX) Can Afford To Drive Business Growth - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Fri, 25 Sep 2026 10:42:10 GMT","We Think Immix Biopharma (NASDAQ:IMMX) Can Afford To Drive Business Growth Simply Wall Street","Simply Wall Street",{"title":224,"link":225,"pubDate":226,"description":227,"source":228},"Immix Biopharma closes $117.1m stock offering - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxPZ0xXRlpvZFpJa1ZDMkdyMXFpcVhWaURPSlBIVnlPQUVEU3QxRG0yQWg5RWZsdmlUV0lPbFZoOUpqVkVhbFdQRlJWQUE5cWpNcXVVTFg1OVh4Skd5WlZvQ3pvZG5kMUNQc3Z1MjZxMG16UFBVay13ZXk2dGlWaGUxbjE3aVZlNWxneVNZMTl5MzdJeVF0Tk1JSHBBMVpoYWcyOHc?oc=5","Wed, 30 Sep 2026 21:40:28 GMT","Immix Biopharma closes $117.1m stock offering Investing.com","Investing.com",{"title":230,"link":231,"pubDate":232,"description":233,"source":234},"Immix Biopharma Closes $125 Million Stock Offering - marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxPRUJQaExrWnRBNi01bWpuT3NNRWxaQ2M0MmVNVGpHc19tU04wT21hcER3QWpEaHlRbm1qWnFTSU9hRVpWMWlkaWhzRXVQQXdRM3JCdmxSRU9qcDBFMWVHczdPcXlhMWJ2Y2NTM3lqY3BFcUlDLVZ4bXFHdTB5djYxdUR2ZWJMcWVKOGtwMGhybDlNUENZWFVmZ2lZMWVwOEg0WWx1NQ?oc=5","Wed, 30 Sep 2026 21:37:11 GMT","Immix Biopharma Closes $125 Million Stock Offering marketscreener.com","marketscreener.com",{"title":236,"link":237,"pubDate":238,"description":239,"source":181},"San Francisco will host Immix Biopharma’s presentation Jan. 11–14. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitgFBVV95cUxNak9jN3MxTVFjdnZjS0JMbk93aHNzaEhfR1J4b0NzM3ZrUWZMSXJNa1JuZkFKMjF1clRDYS1URm1aWXBTX2lkNWowTGRLRmxnZzF4V3BneF9JTXJCcGluUUlkdDlZSUREb2c4clhBMXZCOXZBR25vMWs1TEc1akc3Z1Z5WVJycU0wSlR6QnhueS0waTFaZmN2Rk5IZDhvZGNNWHBaUHlrTzh0cDJSU0plNkJPSllWQQ?oc=5","Mon, 05 Oct 2026 12:48:36 GMT","San Francisco will host Immix Biopharma’s presentation Jan. 11–14. Stock Titan",{"title":241,"link":242,"pubDate":243,"description":244,"source":245},"A Quick Look at Today's Ratings for Immix Biopharma(IMMX.US), With a Forecast Between $24 to $30 - Moomoo","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxNTkQ4aFNVQkhWREVYSXJVMTM2bzFVVTRoaXYzbUVNdENlWWx1WHI4bkVUQnBwMV8wU0hkZnp6UmNJNENTOUw1MGdxa3J6eTVCVl9TZy05T3p1WFBINGh6V1RSM2plS0NSWUNHeVZLcHNlQURMS1FQbTZRYXFBckxNX0R4bzhDZmhsTGo3Q2JLX3Z3cElLanNiQTlfOA?oc=5","Wed, 30 Sep 2026 13:00:01 GMT","A Quick Look at Today's Ratings for Immix Biopharma(IMMX.US), With a Forecast Between $24 to $30 Moomoo","Moomoo",{"title":247,"link":248,"pubDate":249,"description":250,"source":204},"Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock - GlobeNewswire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi7wFBVV95cUxQbWJPSTgwcWZNRWVEbXBCQVd4em9KRDJUMEkxQmw0WmZMNHBHX3RiX0tDLXJkRnR6RU4xbnRjX1o4cjNFclY5dVMzS3gwekxQWWQ5VGRzSDBGTUhKRlloYkVMd3g3TmU5ZFJRSmNWRGhkakxkNzlqVXMtbHdFajF5d1dnOFZmc3h1V05aYjBkWjdXSjhwck11UHc2TEdlcnMxRFVUNGxaYUNmNnc3RHZ0X01jZVMtOWowX1BjY01XUHloYjZidGtmR19fOERuNHFQTHJUekthOGo0STh2bkxDYmNkY1hsMWpSb19sOHp1TQ?oc=5","Tue, 29 Sep 2026 11:05:00 GMT","Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock GlobeNewswire",{"title":252,"link":253,"pubDate":254,"description":255,"source":181},"All 25 new patients had a complete response or tested negative for remaining disease - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxON0t6ZzBodEI4aUkxQ2x3N0FDNk83QVU4cFdaTDhoMFc1aG9kT2luN2ZPY0xIMDRSc2dtbDJzTlF3VzRuZWVuNGJSWjFpenVtOUttRU5LMVg4eHQ5ZFRyZnhHLWJyT2tzcmIyWmlnMHE5QXBFMXVTVTYwN2JlOGxrWmh1OF9PdlhQN2E3VVhRX19LODNvWjgzb2Fja01Rb1NsUnBPeEJPQnpNWVhKdmR2elR2bDFVVkVD?oc=5","Tue, 29 Sep 2026 11:00:00 GMT","All 25 new patients had a complete response or tested negative for remaining disease Stock Titan",{"title":257,"link":258,"pubDate":259,"description":260,"source":216},"Needham maintains Buy rating on Immix Biopharma, $30 price target - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxQdjhtSWc5U0lGVjBMZ3RKcUdUUGhCal9nQmVvcnVwVWVkOWVQS0xBVWxGMEN6M25KaDlDbDZ3Z204MzdIWWlUZFFldnNIT0pTMzE2VnpPNDFlSjI2aWlYM2RGVEREa25GZWtIYnZWMVN1YUZpTGtTdEd5S2lWdkdiMzBDa1V1ODRUVXJlbWNQUm8xRkg1eU1RSWtodnd0X3ViR0JZbUx1S3ZwX0k4TlVxNndmcXZlRE5SQUphZmE1UU5DcEk?oc=5","Tue, 29 Sep 2026 16:54:00 GMT","Needham maintains Buy rating on Immix Biopharma, $30 price target TradingView",{"title":262,"link":263,"pubDate":264,"description":265,"source":234},"Transcript : Immix Biopharma, Inc. - Shareholder\u002FAnalyst Call - marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirAFBVV95cUxOd3hQN2pMZjJ6WUNiZUxqUGNoTjE5WjR6YmVwTXZ1djVRTUxnVGtKUjFwVl9ka3dTYUhSMTFFejRjSVlQM3QyRGx3NmdHamVNeTJKNjdDRWRHeE1WN284UTB6ZHRDNUxFdU5DdUhaRUYxSkR5Sy03LVlPVXJDZE85eTJDTFhmTTdkeXRCTVFpcVlxNXZibV9uYXFLZXVyU3Qwdmc1TFhkUzlBOWVp?oc=5","Tue, 29 Sep 2026 13:50:30 GMT","Transcript : Immix Biopharma, Inc. - Shareholder\u002FAnalyst Call marketscreener.com",{"title":267,"link":268,"pubDate":269,"description":270,"source":271},"Immix Biopharma prices $125M stock offering at $11 per share - Investing.com India","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxOOEMtVGpKUTNHVHhjVzdURzNrdTdXbmZHX0tMaG9ONUdRNzNwa0pDa1FfMFlkRVoxUkVVRmZZT2o4eC1lTnRYVmI0em5LbDhaYTQ4VkdFZEFrS1FhRXpJRjhpZVk5QjYzYVZzbWFOSEdfczJNUXZXTGo0VWZVM0JUSXRjcU9qVG9teU52ZEg1ZGEwLXJLZXJ6RE9pQThnMUtyMXJrU29wOFBoU1RwX0ZRTVA0VHNrRVRSWGhJ?oc=5","Tue, 29 Sep 2026 11:50:52 GMT","Immix Biopharma prices $125M stock offering at $11 per share Investing.com India","Investing.com India",{"title":273,"link":274,"pubDate":275,"description":276,"source":271},"Citizens reiterates Immix Biopharma stock rating on trial data By Investing.com - Investing.com India","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxOVXZPX3JvTVNudTFpSElYZERjd3NIRzJwTy00OGJPeVFmRzg2dU51NC11NjZWMmFJcU1wZ3BBanlmVVNrWTdLTzl1U0RxUVVHdVpLSWJRSWVZMXZIcGFZSFRSb19NNG55MWFIMUxnaTQ1MGRJWGdHejZTbVlrT1FtaXV2aWoyNktZN2h6bGlLWVZNekNZQk94bEFWcHVyaU9qaXM2TzRmZDRWR3dZOWdyMEp4eTFUZnFWZ1U2RVFnNW0?oc=5","Wed, 30 Sep 2026 09:31:05 GMT","Citizens reiterates Immix Biopharma stock rating on trial data By Investing.com Investing.com India",{"title":278,"link":279,"pubDate":280,"description":281,"source":282},"Needham initiates coverage on Immix Biopharma with Buy rating - scanx.trade","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxOWVVUZzg3eF90ZXNVWVJURGQ1Z3lUR0Q2TGxOU3dLVUJEaVRkbjBRNW4zYzhMd1ctZXdhSXd1ZjdyMkNXcGdKa2VZb1MzdnAzSThKQ3FaejkwS29Va2x3dmVNWWJ6QXI2UWVuelJfUFZBX2ktRHhQcUMyMmc3WEdmRDdMejhXMlVseVRVdkJsWVVzZUdDMnhkYURVWkVkMDRNNFE1c29VRTdOV0RZbmNucnhGcTlJMnlLWGNCWDAxOTMtcFU?oc=5","Sat, 03 Oct 2026 08:45:16 GMT","Needham initiates coverage on Immix Biopharma with Buy rating scanx.trade","scanx.trade",{"title":284,"link":285,"pubDate":286,"description":287,"source":288},"Immix Biopharma reports promising interim Phase 2 results - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirgFBVV95cUxOdXJGUFoydldPNHVDdldtLUpFU21nUFRkaEg0TEo3eDFDRC1UeVVjOU8wa2g4bmFudk02Zk1sQVctZFhJd3Z6aDUtcjNZXzhFMWdvZEJhNThBdHRjOFBXV0RYelZjdnlhNE1iZEJQLVJvaU8wN0p4YktQdTc5Y3RwNExqM1AwRnY3ekR3VW5sbXd5SGFRaElHdkRsSWhWYTFVZ1pKVVFGZjZkZTJEU1E?oc=5","Tue, 29 Sep 2026 11:40:48 GMT","Immix Biopharma reports promising interim Phase 2 results TipRanks","TipRanks"]